Gene · 6528
Papers4,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Partitioning and aggregating cross-tissue and tissue-specific genetic effects to identify gene-trait associations. | Nat Commun | 2024 | 38982044 | PubTator, text mining | PubMed |
| Origins of Temperature-Dependent Anomeric Selectivity in Glycosylations with an L-Idose Thioglycoside. | Chemistry | 2024 | 38977407 | PubTator, text mining | PubMed |
| An age-and sex-matched postoperative therapy should be required in thyroid papillary carcinoma. | Front Endocrinol (Lausanne) | 2024 | 38974575 | PubTator, text mining | PubMed |
| Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use. | Mol Imaging Biol | 2024 | 38958882 | PubTator, text mining | PubMed |
| Enhanced decision technique for optimized crude oil pretreatment under disc spherical fuzzy Aczel Alsina aggregation information. | Sci Rep | 2024 | 38956079 | PubTator, text mining | PubMed |
| Combining Nuclear Medicine With Other Modalities: Future Prospect for Multimodality Imaging. | Mol Imaging | 2024 | 38952398 | PubTator, text mining | PubMed |
| Update on lacrimal apparatus dysfunction associated with differentiated thyroid cancer after I-131 therapy. | Int Ophthalmol | 2024 | 38909080 | PubTator, text mining | PubMed |
| High Fatty Acid-Binding Protein 4 Expression Associated with Favorable Clinical Characteristics and Prognosis in Papillary Thyroid Carcinoma. | Endocr Pathol | 2024 | 38884688 | PubTator, text mining | PubMed |
| Insurance payor status and risk of major adverse cardiovascular and cerebrovascular events after metabolic and bariatric surgery. | Surg Obes Relat Dis | 2024 | 38849260 | PubTator, text mining | PubMed |
| Pitfalls of Iodine-131 Whole-Body Scan Mimicking Metastases in Differentiated Thyroid Carcinoma: A Case Series. | Indian J Nucl Med | 2024 | 38817715 | PubTator, text mining | PubMed |
| In Vitro and Preclinical Systematic Dose-Effect Studies of Auger Electron- and β Particle-Emitting Radionuclides and External Beam Radiation for Cancer Treatment. | Int J Radiat Oncol Biol Phys | 2024 | 38797497 | PubTator, text mining | PubMed |
| Assessing indoor positioning system: A q-spherical fuzzy rough TOPSIS analysis. | Heliyon | 2024 | 38778951 | PubTator, text mining | PubMed |
| Metabolomics reveals the implication of acetoacetate and ketogenic diet therapy in radioiodine-refractory differentiated thyroid carcinoma. | Oncologist | 2024 | 38760956 | PubTator, text mining | PubMed |
| Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface. | J Transl Med | 2024 | 38760813 | PubTator, text mining | PubMed |
| Molecular Imaging and Therapy of Differentiated Thyroid Carcinoma in Adults. | Cancer J | 2024 | 38753754 | PubTator, text mining | PubMed |
| Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis. | Nat Commun | 2024 | 38750011 | PubTator, text mining | PubMed |
| Transcriptomic characteristics according to tumor size and SUVmax in papillary thyroid cancer patients. | Sci Rep | 2024 | 38745021 | PubTator, text mining | PubMed |
| Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography. | Eur J Nucl Med Mol Imaging | 2024 | 38722382 | PubTator, text mining | PubMed |
| Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line. | J Endocrinol Invest | 2024 | 38698299 | PubTator, text mining | PubMed |
| Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells. | Viruses | 2024 | 38675909 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6528/papers?page=14